Shorter Course Of Rifampin As Safe And Effective As Longer Course Of Isoniazid At Preventing Active Tuberculosis In Two Phase 3 Trials.

Medscape (8/1, Frellick, Subscription Publication) reports researchers found in two phase 3 trials that four months of rifampin may be as safe and effective as nine months of isoniazid at preventing active tuberculosis in patients with latent tuberculosi...